Picture [LSE] – The Business Web Portal 650x65px

News > All

Total search results: 9852 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 69 70 71 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Bayer AG. (1/10/13). "Press Release: Bayer Receives Approval for New Long-term Contraceptive Skyla in the U.S.. New Low Dose Levonorgestrel-releasing Intrauterine System (IUS) – Longterm Contraception for Up to Three Years [Not intended for U.S. and UK m 2013-01-10
Proteo Biotech AG. (1/10/13). "Press Release: FDA Grants Proteo Orphan Drug Designation to Elafin for the Treatment of Pulmonary Arterial Hypertension". Irvine, CA & Kiel. 2013-01-10
Evotec AG. (1/9/13). "Press Release: Evotec and Yale University Form Open Innovation Alliance". Hamburg. 2013-01-09
SIRS-Lab GmbH / Leonhardt Rechtsanwälkte Insolvenzverwalter Notare. (1/9/13). "Press Release: Investor Search for Molecular Diagnostics Company Started. Diagnostics Company SIRS-Lab Insolvent". Jena. 2013-01-09
Biotest AG. (1/9/13). "Press Release: Biotest AG’s Supervisory Board Extends the Term of CEO Prof. Schulz and Appoints Dr. Floß to the Board of Management". Dreieich. 2013-01-09
Biomax Informatics AG. (1/9/13). "Press Release: Biomax Informatics Provides Knowledge Management and Semantic Software Technology, with European STATegra Project, Enabling Integrated Biological Systems Analysis". Planegg. 2013-01-09
Debiopharm S.A.. (1/9/13). "Press Release: Spinomix Closes a $ 3 Million Financing Round Led by Debiopharm Group". Lausanne. 2013-01-09
4SC AG. (1/8/13). "Press Release: 4SC Obtains Key Patent for Anti-cancer Compound Resminostat in Europe". Planegg-Martinsried. 2013-01-08
Lonza Group Ltd.. (1/8/13). "Press Release: Lonza to Expand Antibody Drug Conjugate (ADC) Manufacturing Capacity to Meet Growing Customer Demand". Basel. 2013-01-08
CLC bio A/S. (1/8/13). "Press Release: J. Craig Venter Institute Extends CLC bio Site License through 2017". Aarhus. 2013-01-08
Bayer AG. (1/8/13). "Press Release: Bayer CropScience Acquires Germany-based Biocontrol Company Prophyta GmbH". Monheim. 2013-01-08
Debiopharm S.A.. (1/8/13). "Press Release: Chugai and Debiopharm Group Announce an Exclusive License Agreement for Anti-cancer Agent FF284 (Debio 1347)". Lausanne & Tokyo. 2013-01-08
Formycon AG. (1/8/13). "Press Release: Formycon AG Begins Development of First Biosimilar Drug". Munich. 2013-01-08
Miltenyi Biotec GmbH. (1/7/13). "Press Release: Miltenyi Biotec Distributes and Supports FlowJo 10 Software in Europe". Bergisch Gladbach. 2013-01-07
Cell Signaling Technology, Inc.. (1/7/13). "Press Release: Cell Signaling Technology Granted Patent for PCR Methods for Detection of a Subset of Treatable Non-small Cell Lung Cancers". Danvers, MA. 2013-01-07
Ethris GmbH. (1/7/13). "Press Release: Ethris Announces Research Based Alliance on SNIM Modified RNA with Shire". Munich. 2013-01-07
Evotec AG. (1/7/13). "Press Release: Evotec Expands Collaboration with MedImmune, Receives Milestone Payment". Hamburg. 2013-01-07
High-Tech Gründerfonds Management GmbH. (1/7/13). "Press Release: Drug Response Dx Concludes First Round of Financing with Support from Qiagen and High-Tech Gründerfonds". Hennigsdorf, Bonn & Hilden. 2013-01-07
Priaxon AG. (1/7/13). "Press Release: Priaxon Enters Collaboration with GSK on Protein-Protein-Interactions". Munich. 2013-01-07
Qiagen N.V.. (1/7/13). "Press Release: Qiagen Adds to Pipeline of Personalized Healthcare Diagnostics through Agreements for Promising New Biomarkers". Hilden & Germantown, MD. 2013-01-07
Epizyme, Inc.. (1/7/13). "Press Release: Epizyme, Eisai and Roche to Develop EZH2 Companion Diagnostic. Collaboration Focused on Genetically Defined Lymphomas". Cambridge, MA. 2013-01-07
Addex Therapeutics S.A.. (1/7/13). "Press Release: Addex Announces Positive Data with ADX71441 in a Pre-clinical Transgenic Model of Charcot-Marie-Tooth 1A Disease". Geneva. 2013-01-07
Bayer AG. (1/7/13). "Press Release: Bayer Submits VEGF Trap-eye (aflibercept) for Treatment of Macular Edema Following Central Retinal Vein Occlusion in Japan". Berlin. 2013-01-07
Boehringer Ingelheim. (1/7/13). "Press Release: Boehringer Ingelheim and Eli Lilly and Company Announce Positive Top-line Pivotal Phase III Data Results for Empagliflozin [Ex US & UK Medical Media Only]". Ingelheim. 2013-01-07
Boehringer Ingelheim. (1/7/13). "Press Release: Lilly Reassumes Sole Worldwide Development and Commercialization Rights for Novel Basal Insulin Analog. Announces It Will Begin Remainder of Pre-planned Clinical Trials for LY2605541". Indianapolis, IN & In 2013-01-07
Bayer AG. (1/4/13). "Press Release: Bayer HealthCare Completes Acquisition of Teva’s U.S. Animal Health Business [Not intended for U.S. media]". Leverkusen. 2013-01-04
Bruker Corporation. (1/3/13). "Press Release: Bruker and Erasmus Medical Center Sign an Exclusive Licensing Agreement for Adding Rapid Beta-Lactamase Testing Capabilities to the MALDI Biotyper System". Bremen. 2013-01-03
Cevec Pharmaceuticals GmbH. (1/3/13). "Press Release: Cevec Pharmaceuticals and Vakzine Projekt Management Sign Exclusive License Agreement on the Clinical Development of a Novel Human Cytomegalovirus (CMV) Vaccine". Cologne. 2013-01-03
Evotec AG. (1/3/13). "Press Release: Evotec Acquires Cell Culture Service GmbH. Strenghtens Cell-based Screening and Reagent Platform at Evotec’s Hamburg Site". Hamburg. 2013-01-03
Pfizer Inc.. (1/3/13). "Press Release: EMD Serono and Pfizer Announce FDA Approval of Rebif Rebidose (interferon beta-1a). The Majority of Patients Found Rebif Rebidose Easy to Use in a User Trial". Rockland, MA & New York, NY. 2013-01-03
Zellkraftwerk. (1/3/13). "Press Release: Zellkraftwerk Announces Early Access Program. Select Drug Developers to Obtain Pre-release Access to Groundbreaking Cellular Biomarker Discovery Platform". Hannover. 2013-01-03
Bayer AG. (1/3/13). "Press Release: Phase III DECISION Trial of Nexavar (sorafenib) Meets Primary Endpoint of Improving Progression-free Survival in Patients with Radioactive Iodine Refractory Differentiated Thyroid Cancer [Not intended for U.S. and UK m 2013-01-03
Miltenyi Biotec GmbH. (1/3/13). "Press Release: Nordic Working – the New Miltenyi Biotec Team in Lund, Sweden". Bergisch Gladbach. 2013-01-03
Evotec AG. (1/2/13). "Press Release: Evotec and Apeiron Biologics Announce Collaboration on Cancer Immunotherapy". Hamburg. 2013-01-02
Sphingotec GmbH. (1/2/13). "Press Release: Sphingotec Announces Launch of Blood Test for Breast Cancer Prediciton. Proneurotensin (pro-NT) Is a Unique Biomarker for Breast Cancer Prediction in Women". Hennigsdorf. 2013-01-02
Abbott. (1/2/13). "Press Release: Abbott Completes Separation of Research-based Pharmaceuticals Business". Abbott Park, IL. 2013-01-02
Lonza Group Ltd.. (12/28/12). "Press Release: Lonza Completes the Divestiture of Its Brandenburg, KY Performance Urethanes and Organics Business to Monument Chemical". Basel & Indianapolis, IN. 2012-12-28
Epigenomics AG. (12/21/12). "Press Release: Epigenomics AG. Notice of Loss Pursuant to § 92 par. 1 AktG (Ad hoc release) [Not for distribution in the United States]". Berlin. 2012-12-21
Novartis AG. (12/21/12). "Press Release: Novartis Drug Exjade Approved by European Commission for Iron Overload in Patients with Non-transfusion-dependent Thalassemia". Basel. 2012-12-21
Octpaharma AG. (12/21/12). "Press Release: Octapharma Wins Major Tender Victory in Norway". Lachen. 2012-12-21
Sanochemia Pharmazeutika AG. (12/21/12). "Pressemitteilung: Vorläufige Zahlen für das Geschäftsjahr 2011/12". Wien. 2012-12-21
Sanochemia Pharmazeutika AG. (12/21/12). "Pressemitteilung: Änderungen in der Geschäftsführung der Sanochemia Pharmazeutika AG". Wien. 2012-12-21
Cevec Pharmaceuticals GmbH. (12/20/12). "Press Release: Cevec Pharmaceuticals Signs License Agreement with Yuhan Corporation". Cologne. 2012-12-20
Biotest AG. (12/20/12). "Press Release: FDA Approves Biotest’s Bivigam, an Intravenous Immune Globulin (Human), 10% Liquid". Dreieich & Baco Raton, FL. 2012-12-20
Epigenomics AG. (12/20/12). "Press Release: Epigenomics AG Provides Update on Financing Plan [Not for distribution in the United States]". Berlin & Seattle, WA. 2012-12-20
Galenica Holding AG. (12/20/12). "Press Release: PA21 Dossier Sent for Submission to EMA to Seek Approval in the EU". 2012-12-20
Sygnis Pharma AG. (12/20/12). "Press Release: Sygnis Announces the Adaptation of Its Organisation to the New Business Activity". Heidelberg. 2012-12-20
Addex Therapeutics S.A.. (12/20/12). "Press Release: Addex Scientists Discover and Characterize the First Potent and Selective Small Molecule Negative Allosteric Modulator Targeting mGlu7 Receptor". Geneva. 2012-12-20
Evolva Holding S.A.. (12/20/12). "Press Release: Evolva Successfully Discussed Clinical Development Plans for EV-077 in Diabetes Patients with German Regulatory Authority". Reinach. 2012-12-20
Epigenomics AG. (12/19/12). "Press Release: Epigenomics Provides Additional Data of Its Head-to-Head Comparison Study of Epi proColon to FIT". Berlin & Seattle, WA. 2012-12-19
Intercell AG. (12/19/12). "Press Release: Intercell Receives CHMP Positive Opinion for the Pediatric Indication of Its Japanese Encephalitis Vaccine in Europe". Vienna. 2012-12-19
Lonza Group Ltd.. (12/19/12). "Press Release: Lonza and Sartorius Stedim Biotech Enter Collaboration, Supply and Distribution Agreement in the Field of Cell Culture Media". Basel. 2012-12-19
Analytik Jena AG. (12/18/12). "Press Release: Group Figures for the 2011/2012 Financial Year. Analytik Jena Exceeds Forecasts and Confirms Preliminary Figures". Jena. 2012-12-18
Sartorius Stedim Biotech GmbH. (12/18/12). "Press Release: Sartorius Stedim Biotech Expands PAT Software Portfolio for Optimization of Biopharmaceutical Development and Manufacturing Processes". Göttingen. 2012-12-18
LabVantage Solutions Inc.. (12/18/12). "Press Release: Süd-Chemie Migrates from SQL*LIMS to Labvantage 6". Somerset, NJ. 2012-12-18
4SC AG. (12/17/12). "Press Release: 4SC Discovery and BioNTech Announce Exclusive Research and License Agreement for 4SC’s TLR Agonists for Cancer Immunotherapy". Planegg-Martinsried & Mainz. 2012-12-17
Evotec AG. (12/17/12). "Press Release: Evotec Announces NMDA Antagonist License Agreement". Hamburg. 2012-12-17
Vivalis S.A.. (12/16/12). "Press Release: Proposed Merger of Equals between Vivalis and Intercell. Creation of a European Biotech Leader in Vaccines and Antibodies [Not for Distribution in Australia, Canada, Japan or the United States]". Nantes & Vienna. 2012-12-16
MorphoSys AG. (12/16/12). "Press Release: Bio-Rad to Acquire MorphoSys’s Research and Diagnostic Antibody Business AbD Serotec. MorphoSys to Increase Focus on Therapeutics". 2012-12-16
Basilea Pharmaceutica Ltd.. (12/14/12). "Press Release: Basilea Reports Recruitment Completion of Phase 3 Pivotal Study of Isavuconazole, an Agent for the Potential Primary Treatment of Invasive and Life-threatening Fungal Infections". Basel. 2012-12-14
Fresenius SE & Co. KGaA. (12/14/12). "Press Release: Fresenius Announces Decision on Biotechnology Business". Bad Homburg v. d. H.. 2012-12-14
Cube Biotech GmbH. (12/13/12). "Press Release: Startup Cube Biotech Attracts Financing from Creathor Venture". 2012-12-13
Sanochemia Pharmazeutika AG. (12/13/12). "Pressemitteilung: Öffentliches Angebot der Unternehmensanleihe beendet". Wien. 2012-12-13
Biocartis S.A.. (12/12/12). "Press Release: Biocartis Completes €34.5 Million ($44.5 Million) Series D Fund Raising". Lausanne. 2012-12-12
4SC AG. (12/12/12). "Press Release: 4SC Announces Positive Interim Results from Clinical Phase I/II Trial with Anti-cancer Compound Resminostat in Colorectal Cancer". Planegg-Martinsried. 2012-12-12
Roche. (12/12/12). "Press Release: Roche to Invest 240 Million Swiss Francs in Diagnostics Production in Germany. New Penzberg Production Facility Will Help Meet Rising Demand for Diagnostic Products". Basel. 2012-12-12
Wilex AG. (12/12/12). "Press Release: Wilex Inc. Signs Distribution Agreement with Immundiagnostik AG for D-A-CH Region". Munich & Bensheim. 2012-12-12
CLC bio A/S. (12/12/12). "Press Release: CLC bio Part of $7.8m EU STATegra Grant to Develop Integral Analysis Platform for Epigenetics". Aarhus. 2012-12-12
Biotest AG. (12/11/12). "Press Release: Biotest AG Signs Strategically Significant Agreement to Market Human Albumin in China". Dreieich. 2012-12-11
Scienion AG. (12/11/12). "Press Release: Scienion’s sciFlexarrayer Used for the Production of Anagnostics’ Integrated Sepsis Testing Products". Dortmund & St. Valentin. 2012-12-11
Boehringer Ingelheim. (12/11/12). "Press Release: Boehringer Ingelheim Discontinues Phase II Trial in Patients with Artificial Heart Valves [For Non-US, Non-UK & Non-Canadian Media Only]". Ingelheim. 2012-12-11
Basilea Pharmaceutica Ltd.. (12/10/12). "Press Release: Basilea Appoints Ronald Scott as CEO to Succeed Anthony Man and Expands Management Team". Basel. 2012-12-10
Bruker Corporation. (12/10/12). "Press Release: Bruker Announces Multiple Placements of MALDI Biotyper Systems with Various German Federal, State and Local Government Authorities". Bremen. 2012-12-10
PDC Biotech GmbH. (12/10/12). "Press Release: PDC Biotech GmbH Announces Successful Clinical Phase I for Its Lead Compound PDC31". Vienna. 2012-12-10
Anagnostics Bioanalysis GmbH. (12/10/12). "Press Release: Anagnostics Enters Sales Cooperation with Analis S.A. for Belgium and Luxembourg". 2012-12-10
High-Tech Gründerfonds Management GmbH. (12/10/12). "Press Release: Easily Improving Efficiency. Sota Solutions Receives Seed Investment". Berlin, Bielefeld & Bonn. 2012-12-10
Universität Stuttgart. (12/10/12). "Pressemitteilung: Uni Stuttgart und Oncomatrix starten Forschungskooperation. Neue Krebsmedikamente für die Behandlung metastasierender Tumore". 2012-12-10
Biognosys AG. (12/7/12). "Press Release: Closing of Financing Round and New CEO". 2012-12-07
University of Mainz (Johannes-Gutenberg-Universität, JGU). (12/7/12). "Press Release: Launch of the EU Large-scale Integrating Project »BlueGenics« to Combat Osteoporosis". 2012-12-07
Universität Mainz. (12/7/12). "Pressemitteilung: Ausgründungen aus der Universitätsmedizin Mainz feiern Richtfest des neuen Mainzer Biotech-Forschungszentrums". 2012-12-07
Agilent Technologies Inc.. (12/6/12). "Press Release: Agilent Technologies Announces New Version of Intelligent System Emulation Technology, Emulating Waters Alliance LC Systems". Santa Clara, CA. 2012-12-06
Merck KGaA. (12/6/12). "Press Release: Constantin Fest to Head Merck Investor Relations". Darmstadt. 2012-12-06
RainDance Technologies, Inc.. (12/6/12). "Press Release: MLL Munich Leukemia Laboratory Pairs RainDance ThunderStorm System with Illumina MiSeq for Acute Myeloid Leukemia Sequencing". Lexington, MA & Munich. 2012-12-06
Sygnis Pharma AG. (12/6/12). "Press Release: Sygnis Announces Completion of the X-Pol Biotech Acquisition. Registration of the Transaction and the Previous Capital Reduction (Ratio 8:1) in the Commercial Register". Heidelberg. 2012-12-06
Uniqure B.V.. (12/6/12). "Press Release: Uniqure Appoints Hans Christian Rohde Chief Commercial Officer". Amsterdam. 2012-12-06
European ScreeningPort GmbH. (12/6/12). "Press Release: European ScreeningPort Receives Funding for IMI Call4 – Understanding and Optimising Binding Kinetics in Drug Disocvery". Hamburg. 2012-12-06
Max Planck Society for the Advancement of Science. (12/6/12). "Press Release: Grand Opening of Max Planck Florida Institute in the USA". 2012-12-06
Boehringer Ingelheim. (12/5/12). "Press Release: Boehringer Ingelheim and Apexigen Sign Manufacturing Agreement for Process Development and Early Stage Clinical Supply". Ingelheim. 2012-12-05
Roche. (12/5/12). "Press Release: Roche and the Innovative Medicines Initiative Join Forces to Promote Use of Nobel Prize-winning Stem Cell Technology to Enhance Drug Development". Basel. 2012-12-05
Biocartis S.A.. (12/5/12). "Press Release: Biocartis Announces Commercial Launch of a New Biomarker Analysis Platform". Lausanne. 2012-12-05
Biobase GmbH. (12/5/12). "Press Release: ANNOVAR Appoints Biobase for Commercial Distribution". 2012-12-05
Apeiron Biologics AG. (12/4/12). "Press Release: Apeiron Biologics Establishes Biotech-spinoff Attoquant Diagnostics". Vienna. 2012-12-04
Wilex AG. (12/4/12). "Press Release: Wilex AG Announces Restructuring". Munich. 2012-12-04
Epigenomics AG. (12/4/12). "Press Release: Epigenomics AG Reports Non-inferiority of Blood-based Epi proColon against Fecal Immunochemical Testing in Detection of Colorectal Cancer in a Head-to-Head Comparative Study". Berlin & Seattle, WA. 2012-12-04
Sirion Biotech GmbH. (12/4/12). "Press Release: Adeno-associated Virus Now Easily Available for Research and Preclinical Studies". Munich, Bielefeld & Heidelberg. 2012-12-04
Analytik Jena AG. (12/3/12). "Press Release: Analytik Jena Acquires a Stake in Japanese Company Techno X". Jena & Osaka. 2012-12-03
Partec GmbH. (12/1/12). "Press Release: Dramatic Cost Reduction of the Lifelong Immune Status Monitoring of HIV/AIDS Patients. Diganostic Support by More than 3 Million Tests per Year – 1000th CyFlow Counter II Device Manufactured by Partec". Cape Town & 2012-12-01
Austrian Drug Screening Institute. (11/30/12). "Press Release: High Content Screening with Tailored Clinically Relevant Assays". Innsbruck. 2012-11-30
Imperial College London. (11/30/12). "Press Release: National Phenome Research Facility to Open at Imperial. The MRC-NIHR Phenome Centre Will Open at Imperial College London". 2012-11-30
Agennix AG. (11/30/12). "Press Release: Agennix AG Reports Financial Results for Third Quarter and First Nine Months of 2012". Planegg & Princeton, NJ. 2012-11-30
next pagenext page 1 2 3 ... 69 70 71 ... 97 98 99  next pagenext page


Picture [LSUS] – The Business Web Portal 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top